Loading…
Dietary Supplement Listing Act of 2022
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,357 other S bills in the 117th — cohort avg 38d
Dietary Supplement Listing Act of 2022 This bill imposes various requirements on dietary supplements, including by requiring the person (an individual or entity) responsible for introducing a supplement into interstate commerce to register the supplement with the Food and Drug Administration (FDA). Under this bill, the responsible person must register with the FDA specified information about each dietary supplement to be offered for sale, including (1) a list of all ingredients required by regulation to appear on the label; (2) the conditions of use; (3) any warnings and precautions; (4) certain claims characterizing the relationship between certain nutrients in the supplement and a disease or a health-related condition; (5) the responsible person's contact information; and (6) the locations where the supplement is manufactured, packaged, labeled, or held. For a supplement that is offered for sale on the date that is 18 months after this bill's enactment (the effective date), the responsible person must submit the required information to the FDA no later than 60 days after the effective date. A supplement that is not offered for sale on the effective date may not be offered for sale until the responsible person has submitted the required information. The FDA must establish a system that provides a unique identifier for each registered dietary supplement and a publicly accessible electronic database that allows a user to obtain certain information about a registered supplement.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (13)
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2022 · second_quarter · Food Industry (safety, labeling, etc.)
H.R.841 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 S.1698 - Hemp Access and Consumer Safety Act S. 4090 - Dietary Supplement Listing Act of 2022
Client expense: $160,270 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
S. 253, Cannabidiol and Marihuana Research Expansion Act, all provisions H.R. 6087, Improving Access to Workers Compensation for Injured Federal Workers Act of 2022, all provisions H.R. 3085, Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act of 2021, all provisions H.R. 5030, Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act, all provisions H.R. 1384, Mainstreaming Addiction Treatment (MAT) Act of 2021, all provisions S. 445, Mainstreaming Addiction Treatment (MAT) Act of 2021, all provisions H.R. 2067, Medication Access and Training Expansion (MATE) Act of 2021, all provisions S. 2235, Medication Access and Training Expansion (MATE) Act of 2021, all provisions H.R. 6072, Leveraging Integrated Networks in Communities (LINC) To Address Social Needs Act of 2021, provisions relating to social determinants of health, impact on mental health and social services S. 509, Leveraging Integrated Networks in Communities (LINC) To Address Social Needs Act of 2021, provisions relating to social determinants of health, impact on mental health and social services H.R. 379, Improving Social Determinants of Health Act of 2021, all provisions S. 104, Improving Social Determinants of Health Act of 2021, all provisions S. 3799, Prepare for and Respond to Existing Viruses, Emerging New Threats, and (PREVENT) Pandemics Act, all provisions H.R. 8, Bipartisan Background Checks Act of 2021, all provisions H.R. 1446, Enhanced Background Checks Act of 2021, all provisions S. 1675, Maternal Health Quality Improvement Act, all provisions H.R. 2163, Safe Step Act, all provisions S. 464, Safe Step Act, all provisions H.R. 666, Anti-Racism in Public Health Act of 2021, all provisions S. 162, Anti-Racism in Public Health Act of 2021, all provisions H.R. 5248, Temporary Responders for Immediate Aid in Grave Emergencies (TRIAGE) Act of 2021, all provisions H.R. 6311, Comprehensive Addiction Resources Emergency Act of 2021, all provisions S. 3418, Comprehensive Addiction Resources Emergency Act of 2021, all provisions H.R. 1364, Parity Enforcement Act of 2021, all provisions H.R. 3735, Parity Implementation Assistance Act, all provisions H.R. 7232, 9-8-8 and Parity Assistance Act of 2022, all provisions H.R. 7116, 9-8-8 Implementation Act of 2022, all provisions S. 2938, Bipartisan Safer Communities Act, all provisions S. 4090, Dietary Supplement Listing Act of 2022, all provisions S. 1675, Maternal Health Quality Improvement Act, all provisions H.R. 1667, Dr. Lorna Breen Health Care Provider Protection Act, all provisions S. 610, Dr. Lorna Breen Health Care Provider Protection Act, all provisions H.R. 3753, Parity Implementation Assistance Act, all provisions S. 1962, Parity Implementation Assistance Act, all provisions S. 3904, Healthcare Cybersecurity Act of 2022, all provisions H.R. 4128, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, all provisions S. 2209, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, all provisions H.R. 6000, Cures 2.0 Act, all provisions S. 2416, New Opportunities for Value that Extend Lives (NOVEL) Act of 2021, all provisions H.R. 8152, To provide consumers with foundational data privacy rights, create strong oversight mechanisms, and establish meaningful enforcement, all provisions H.R. 2377, Federal Extreme Risk Protection Order Act of 2022, all provisions H.R. 7910, Protecting Our Kids Act, all provisions S. 2938, Bipartisan Safer Communities Act, all provisions H.R. 7667, Food and Drug Amendments of 2022, all provisions H.R. 7666, Restoring Hope for Mental Health and Well-Being Act of 2022, all provisions H.R. 2503, Social Determinants Accelerator Act of 2021, all provisions S. 3039, Social Determinants Accelerator Act of 2021, all provisions H.R. 7192, Diagnostic Device Advisory Committee Act, all provisions H.R. 3085, Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act of 2021, all provisions H.R. 5218, Collaborate in an Orderly and Cohesive Manner Act, all provisions H.R. 7845, NIH Clinical Trial Diversity Act of 2022, all provisions H.R. 708, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act, all provisions S. 168, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act, all provisions H.R. 4480, Telehealth Coverage and Payment Parity Act, all provisions H.R. 7573, Telehealth Extension and Evaluation Act, all provisions S. 3593, Telehealth Extension and Evaluation Act, all provisions H.R. 5541, Primary and Virtual Care Affordability Act, all provisions H.R. 1306, National Coronavirus Commission Act of 2021, all provisions S. 412, National Coronavirus Commission Act of 2021, all provisions H.R. 1843, COVID-19 Hate Crimes Act, all provisions S. 937, COVID-19 Hate Crimes Act, all provisions H.R. 3778, Nullifying Opportunities for Variants to Infect and Decimate (NOVID) Act, all provisions S. 1976, Nullifying Opportunities for Variants to Infect and Decimate (NOVID) Act, all provisions H.R. 6904, Patients Before Profits Act of 2022, all provisions H.R. 7053, Hospital Inpatient Services Modernization Act, all provisions S. 3792, Hospital Inpatient Services Modernization Act, all provisions H.R. 1364, Parity Enforcement Act of 2021, all provisions H.R. 5224, Preventing Overdoses and Saving Lives Act of 2021, all provisions H.R. 6279, Opioid Treatment Access Act of 2022, all provisions H.R. 7234, Summer Barrow Prevention, Treatment, and Recovery Act, all provisions H.R. 3352, Midwives for MOMS Act of 2021, all provisions H.R. 847, Promoting Digital Privacy Technologies Act, all provisions S. 224, Promoting Digital Privacy Technologies Act, all provisions H.R. 3771, South Asian Heart Health Awareness and Research Act of 2021, all provisions H.R. 7559, Prescription Information Modernization Act of 2022, all provisions H.R. 8289, Banning Misleading Drug Ads Act of 2022, all provisions H.R. 3614, Menstrual Equity For All Act of 2021, all provisions No Surprises Act/implementation Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act, all provisions 21st Century Cures Act/implementation Maternal mortality Maternal health and inequities/FY 2023 funding Prior Authorization AMA Recovery Plan for Americas Physicians/telehealth/prior authorization/physician burnout/scope Section 2527(b) of the U.S. Innovation and Competition Act (USICA)/Open Access Language Retired Physician Re-entry COVID-19 telehealth flexibilities COVID-19/Vaccine distribution/Vaccines in physician offices Physician burnout and suicide COVID-19/Health Equity/vaccines COVID-19 response/testing/misinformation/therapeutics/Paxlovid Public Health Emergency COVID-19 Health Equity/Men who have sex with men/3-month blood donation use deferral Health Equity/Federally qualified health centers and clinical trials Womens Reproductive Health Medication Abortion Access Diabetes Provider Relief Fund/COVID-19 Electronic Health Records (EHR) Certification Data Privacy Hunger, Nutrition, and Health Digital Health/AI/Digital Therapeutics Monkeypox/testing/vaccination
2022 · fourth_quarter · Health Issues
For S.1654 - A bill to amend the Internal Revenue Code of 1986 to include certain over-the-counter dietary supplement products as qualified medical expenses; allowing HSA supplement deduction For S.4367 - A bill to amend the Internal Revenue Code of 1986 to eliminate limitations on contributions to health savings accounts; allowing HSA expansion ForS.3124 - National Patient ID Repeal Act; prohibiting the Patient Identification tracking Against H.R.550 - Immunization Infrastructure Modernization Act of 2021, nationalizing vaccine databases for easier tracking For Amending the Infrastructure Law (PL No: 117-58), to allow wired broadband, not just wireless For H.R.5816 - National Informed Consent Exemption (NICE) Act, allowing exemption for all federally-connected vaccines, and requiring government study of the unvaccinated (to restore Control Group science) Against S. 4090, Dietary Supplement Listing Act, to protect supplement manufacturers from bankruptcy
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Consumer Issues/Safety/Products
Regulation of dietary supplements and natural products. Specifically related to mandatory product listing and increased authority for FDA to combat illegal supplements. S.4090, Dietary Supplement Listing Act. S. 4348, FDASLA Act of 2022. SHOP SAFE Act H.R. 3429/S.1843. INFORM Consumers Act S. 936. America Competes Act of 2022, H.R. 4521.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Food Industry (safety, labeling, etc.)
Regulation of dietary supplements and natural products. Specifically related to mandatory product listing and increased authority for FDA to combat illegal supplements. S.4090, Dietary Supplement Listing Act. S. 4348, FDASLA Act of 2022. SHOP SAFE Act H.R. 3429/S.1843. INFORM Consumers Act S. 936. America Competes Act of 2022, H.R. 4521.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $4,550,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), President of the U.S., SENATE, Vice President of the U.S., White House Office
2022 · fourth_quarter · Food Industry (safety, labeling, etc.)
Regulation of dietary supplements and natural products. Specifically related to mandatory product listing and increased authority for FDA to combat illegal supplements. S.4090, Dietary Supplement Listing Act. S. 4348, FDASLA Act of 2022.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Food Industry (safety, labeling, etc.)
S. 4090, Dietary Supplement Listing Act of 2022, a bill to improve transparency and the availability of information regarding dietary supplements by amending the Federal Food, Drug, and Cosmetic Act to require manufacturers of dietary supplements to list dietary supplements with the Food and Drug Administration.
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Health Issues
Issues concerning the dietary supplement industry, including 1) support for H.R.5214 (and eventual Senate Companion) - To amend the Internal Revenue Code of 1986 to permit expenditures from health savings accounts, flexible spending arrangements, and health reimbursement arrangements for dietary supplements. 2) Mandatory Product Listing for the Dietary Supplement Industry, to be housed at the FDA: S. 4090 3) For the natural substance known as N-Acetyl-L-Cysteine (NAC) to remain legal as a dietary supplement by the FDA. 4) S 4348 - FDA User Free Reauthorization Package (S. 4368) - did not support additional amendments added affecting the supplement industry
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Health Issues
H.R. 708, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act, provisions relating to fraud, waste, and abuse S. 168, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act, provisions relating to fraud, waste, and abuse H.R. 2617, Consolidated Appropriations Act, 2023, provisions relating to COVID-19 telehealth flexibilities H.R. 1364, Parity Enforcement Act of 2021, all provisions H.R. 3753, Parity Implementation Assistance Act, all provisions S. 1962, Parity Implementation Assistance Act, all provisions S. 3799, Prepare for and Respond to Existing Viruses, Emerging New Threats, and (PREVENT) Pandemics Act, provisions relating to hospital-at-home flexibilities H.R. 925, Data to Save Moms Act, all provisions H.R. 959, Black Maternal Health Momnibus Act of 2021, all provisions S. 346, Black Maternal Health Momnibus Act of 2021, all provisions H.R. 6878, Pregnant Women in Custody Act, all provisions S. 5027, Protecting the Health and Wellness of Babies and Pregnant Women in Custody Act, all provisions H.R. 1384, Mainstreaming Addiction Treatment (MAT) Act of 2021, all provisions S. 445, Mainstreaming Addiction Treatment (MAT) Act of 2021, all provisions H.R. 2067, Medication Access and Training Expansion (MATE) Act of 2021, all provisions S. 2235, Medication Access and Training Expansion (MATE) Act of 2021, all provisions H.R. 7234, Summer Barrow Prevention, Treatment, and Recovery Act, all provisions H.R. 8908, Fighting Stimulant and other Substance Use Disorders Act, all provisions H.R. 8891, No Surprises for Survivors Act of 2022, al provisions H.R. 8885, Better Health Care Directories Act, all provisions H.R. 8886, Promoting Clarity in Mental Health and Substance Use Disorder Treatment Act, all provisions H.R. 8892, Access to Mental Health Services Act, all provisions H.R. 8881, Mental Health Transparency Act, all provisions H.R. 8889, Readable Insurance Coverage Explanations (RICE) Act, all provisions S. 5041, Training Psychiatrists for the Future Act, all provisions H.R. 1218, Data Mapping to Save Moms Lives Act, all provisions S. 198, Data Mapping to Save Moms' Lives Act, all provisions S. 1675, Maternal Health Quality Improvement Act, all provisions H.R. 1446, Enhanced Background Checks Act of 2021, all provisions H.R. 8, Bipartisan Background Checks Act of 2021, all provisions H.R. 379, Improving Social Determinants of Health Act of 2021, all provisions S. 104, Improving Social Determinants of Health Act of 2021, all provisions H.R. 2163, Safe Step Act, all provisions S. 464, Safe Step Act, all provisions H.R. 5248, Temporary Responders for Immediate Aid in Grave Emergencies (TRIAGE) Act of 2021, all provisions H.R. 5602, Bolstering Infectious Outbreaks (BIO) Preparedness Workforce Act of 2021, all provisions S. 3244, Bolstering Infectious Outbreaks (BIO) Preparedness Workforce Act of 2021, all provisions H.R. 1667, Dr. Lorna Breen Health Care Provider Protection Act, all provisions S. 3904, Healthcare Cybersecurity Act of 2022, all provisions H.R. 4128, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, all provisions S. 2209, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, all provisions H.R. 6000, Cures 2.0 Act, all provisions H.R. 8152, American Data Privacy and Protection Act, all provisions H.R. 2377, Federal Extreme Risk Protection Order Act of 2022, provisions related to gun violence H.R. 7910, Protecting Our Kids Act, all provisions S. 2938, Bipartisan Safer Communities Act, all provisions H.R. 7667, Food and Drug Amendments of 2022, all provisions H.R. 7666, Restoring Hope for Mental Health and Well-Being Act of 2022, all provisions H.R. 8318, To restrict limitations on the possession, sale, purchase, transportation or use of any contraceptive that relates to interstate commerce, all provisions H.R. 8296, Womens Health Protection Act of 2022, all provisions H.R. 8297, Ensuring Womens Right to Reproductive Freedom Act, all provisions H.R. 8373, Right to Contraception Act, all provisions H.R. 1235, Charlotte Woodward Organ Transplant Discrimination Prevention Act, all provisions H.R. 3301, Charlotte Woodward Organ Transplant Discrimination Prevention Act, all provisions H.R. 8454, Medical Marijuana and Cannabidiol Research Expansion Act, all provisions S. 253, Cannabidiol and Marihuana Research Expansion Act, all provisions H.R. 3085, Equity in Neuroscience and Alzheimers Clinical Trials Act of 2021, all provisions H.R. 5030, Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act, all provisions H.R. 6072, Leveraging Integrated Networks in Communities (LINC) To Address Social Needs Act of 2021, all provisions S. 509, Leveraging Integrated Networks in Communities (LINC) to Address Social Needs Act of 2021, all provisions H.R. 666, Anti-Racism in Public Health Act of 2021, all provisions S. 162, Anti-Racism in Public Health Act of 2021, all provisions H.R. 6311, Comprehensive Addiction Resources Emergency Act of 2021, all provisions S. 3418, Comprehensive Addiction Resources Emergency Act of 2021, all provisions H.R. 7232, 9-8-8 and Parity Assistance Act of 2022, all provisions S. 4090, Dietary Supplement Listing Act of 2022, all provisions No Surprises Act/implementation Hospice Code Modernization Act of 2022 Cybersecurity Climate change and inhalers WIC/Nutrition Opioids/Pain Care and Substance Use Disaster funding/Puerto Rico and Florida Gender reassignment surgery/provider threats Health Equity Long-term care/special needs Data Privacy Prior authorization Artificial Intelligence(AI)/Bias/Equity Digital health/AI/Digital therapeutics Maternal mortality and morbidity/Equity Infectious disease - COVID-19, monkey pox, RSV COVID-19/testing/misinformation/vaccines/therapeutics Opioids Reproductive health Cannabis/marketing/unapproved medical claims Emergency departments/patient boarding Precision medicine/diagnostics Section 1557/nondiscrimination
Client expense: $5,060,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
2022 · fourth_quarter · Food Industry (safety, labeling, etc.)
Potential dietary supplement mandatory product listing program (S. 4090), Dietary Supplement Listing Act, (S. 4348, Food and Drug Administration Safety and Landmark Advancement Act FDASLA, no House companion measure (PL 117-328, Consolidated Appropriations Act, 2023).
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Health Issues
HR 841 Issues related to regulation of dietary supplements S.1698 the Hemp Access and Consumer Safety Act S. 4090 Dietary Supplement Listing Act of 2022 S. 4348 the Food and Drug Administration Safety and Landmark Advancements Act of 2022 S.4591, the Cannabis Administration and Opportunity Act
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Food Industry (safety, labeling, etc.)
FDA regulations and legislation affecting dietary supplements, medical foods and other natural products; regulations and legislation related to foods and dietary supplements containing CBD; Coronavirus impact and response; H.R.841, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021; FY2023 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (H.R.8239, S.4661); S.4090, Dietary Supplement Listing Act of 2022; H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; H.R.2617, Consolidated Appropriations Act, 2023.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Health Issues
Dietary supplement regulation, Mandatory product listing Monitor the following: FTC Regulation Business Opportunity Rule and Penalty Offense Authority, Pending rule making S.3410, The Consumer Protection and Due Process Act, Section 13B FTC issue Essential oils and wellness products related issues and initiatives S.420, Protecting the Right to Organize Act of 2021 (PRO Act), Impact on independent Cosmetics Regulatory reform related issues S.4090, Dietary Supplement Listing Act of 2022, Entirety
Client expense: Not reported · Firm income: $30,000
Government targets: SENATE
2022 · fourth_quarter · Food Industry (safety, labeling, etc.)
S.4348, FDASLA Act of 2022, Mandatory product registration Monitor the following: Regulatory enforcement of dietary supplements, Mandatory product registration issues Food Safety regulation related issues S.4090, Dietary Supplement Listing Act of 2022, Entirety H.R.7667, Food and Drug Amendments of 2022, Entirety Regulatory enforcement of dietary supplements, Mandatory product registration issues Hemp-Derived Cannabidiol (CBD) regulations H.R.841, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021, generally S.1698, Hemp Access and Consumer Safety Act, Entirety Cosmetics Regulatory Reform related issues
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Food Industry (safety, labeling, etc.)
H.R.841 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 S.1698 - Hemp Access and Consumer Safety Act S. 4090 - Dietary Supplement Listing Act of 2022
Client expense: $178,500 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
For S.1654 - A bill to amend the Internal Revenue Code of 1986 to include certain over-the-counter dietary supplement products as qualified medical expenses; allowing HSA supplement deduction For S.4367 - A bill to amend the Internal Revenue Code of 1986 to eliminate limitations on contributions to health savings accounts; allowing HSA expansion ForS.3124 - National Patient ID Repeal Act; prohibiting the Patient Identification tracking Against H.R.550 - Immunization Infrastructure Modernization Act of 2021, nationalizing vaccine databases for easier tracking For Amending the Infrastructure Law (PL No: 117-58), to allow wired broadband, not just wireless For H.R.5816 - National Informed Consent Exemption (NICE) Act, allowing exemption for all federally-connected vaccines, and requiring government study of the unvaccinated (to restore Control Group science) Against S. 4090, Dietary Supplement Listing Act, to protect supplement manufacturers from bankruptcy
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Food Industry (safety, labeling, etc.)
S. 4090, Dietary Supplement Listing Act of 2022, a bill to improve transparency and the availability of information regarding dietary supplements by amending the Federal Food, Drug, and Cosmetic Act to require manufacturers of dietary supplements to list dietary supplements with the Food and Drug Administration.
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Food Industry (safety, labeling, etc.)
Regulation of dietary supplements and natural products. Specifically related to mandatory product listing and increased authority for FDA to combat illegal supplements. S.4090, Dietary Supplement Listing Act. S. 4348, FDASLA Act of 2022. SHOP SAFE Act H.R. 3429/S.1843. INFORM Consumers Act S. 936. America Competes Act of 2022, H.R. 4521.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Consumer Issues/Safety/Products
Regulation of dietary supplements and natural products. Specifically related to mandatory product listing and increased authority for FDA to combat illegal supplements. S.4090, Dietary Supplement Listing Act. S. 4348, FDASLA Act of 2022. SHOP SAFE Act H.R. 3429/S.1843. INFORM Consumers Act S. 936. America Competes Act of 2022, H.R. 4521.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Food Industry (safety, labeling, etc.)
Regulation of dietary supplements and natural products. Specifically related to mandatory product listing and increased authority for FDA to combat illegal supplements. S.4090, Dietary Supplement Listing Act. S. 4348, FDASLA Act of 2022.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
H.R. 6072, Leveraging Integrated Networks in Communities (LINC) to Address Social Needs Act of 2021, provisions relating to social determinants of health, mental health, and social services S. 509, LINC to Address Social Needs Act of 2021, provisions relating to social determinants of health, mental health, and social services H.R. 379, Improving Social Determinants of Health Act of 2021, all provisions S. 104, Improving Social Determinants of Health Act of 2021, all provisions S. 3799, Prepare for and Respond to Existing Viruses, Emerging New Threats, and (PREVENT) Pandemics Act, all provisions H.R. 8, Bipartisan Background Checks Act of 2021, all provisions H.R. 1446, Enhanced Background Checks Act of 2021, all provisions H.R. 1218, Data Mapping to Save Moms Lives Act, all provisions S. 198, Data Mapping to Save Moms' Lives Act, all provisions S. 1675, Maternal Health Quality Improvement Act, all provisions H.R. 1384, Mainstreaming Addiction Treatment (MAT) Act of 2021, all provisions S. 445, MAT Act of 2021, all provisions H.R. 2163, Safe Step Act, all provisions S. 464, Safe Step Act, all provisions H.R. 666, Anti-Racism in Public Health Act of 2021, all provisions S. 162, Anti-Racism in Public Health Act of 2021, all provisions H.R. 5602, Bolstering Infectious Outbreaks (BIO) Preparedness Workforce Act of 2021, all provisions S. 3244, BIO Preparedness Workforce Act of 2021, all provisions H.R. 5248, Temporary Responders for Immediate Aid in Grave Emergencies (TRIAGE) Act of 2021, all provisions H.R. 6311, Comprehensive Addiction Resources Emergency Act of 2021, all provisions S. 3418, Comprehensive Addiction Resources Emergency Act of 2021, all provisions H.R. 1364, Parity Enforcement Act of 2021, all provisions H.R. 3753, Parity Implementation Assistance Act, all provisions S. 1962, Parity Implementation Assistance Act, all provisions H.R. 7232, 9-8-8 and Parity Assistance Act of 2022, all provisions H.R. 2067, Medication Access and Training Expansion (MATE) Act of 2021, all provisions S. 2235, MATE Act of 2021, all provisions S. 2938, Bipartisan Safer Communities Act, all provisions S. 4090, Dietary Supplement Listing Act of 2022, all provisions H.R. 8296, Womens Health Protection Act of 2022, all provisions H.R. 8373, Right to Contraception Act, all provisions H.R. 8318, To restrict limitations on the possession, sale, purchase, transportation or use of any contraceptive that relates to interstate commerce, all provisions H.R. 8454, Medical Marijuana and Cannabidiol Research Expansion Act S. 253, Cannabidiol and Marihuana Research Expansion Act, all provisions S. 2866, Treatment Restoration for Emergency Antibody Therapeutics (TREAT) Act, all provisions H.R. 6087, Improving Access to Workers Compensation for Injured Federal Workers Act of 2022, all provisions H.R. 3085, Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act of 2021, all provisions H.R. 5030, Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act, all provisions S. 1675, Maternal Health Quality Improvement Act, all provisions S. 3904, Healthcare Cybersecurity Act of 2022, all provisions H.R. 4128, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, all provisions S. 2209, VALID Act of 2021, all provisions H.R. 8152, American Data Privacy and Protection Act, all provisions H.R. 2377, Federal Extreme Risk Protection Order Act of 2022, all provisions H.R. 7910, Protecting Our Kids Act, all provisions S. 2938, Protecting Our Kids Act, all provisions H.R. 7667, Food and Drug Amendments of 2022, all provisions H.R. 7666, Restoring Hope for Mental Health and Well-Being Act of 2022, all provisions H.R. 8297, Ensuring Womens Right to Reproductive Freedom Act, all provisions H.R. 1235, Charlotte Woodward Organ Transplant Discrimination Prevention Act, all provisions S. 3301, Charlotte Woodward Organ Transplant Discrimination Prevention Act, all provisions H.R. 708, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act, all provisions S. 168, TREAT Act, all provisions H.R. 4480, Telehealth Coverage and Payment Parity Act, all provisions H.R. 5541, Primary and Virtual Care Affordability Act, all provisions H.R. 1306, National Coronavirus Commission Act of 2021, all provisions S. 412, National Coronavirus Commission Act of 2021, all provisions H.R. 3778, Nullifying Opportunities for Variants to Infect and Decimate (NOVID) Act, all provisions S. 1976, NOVID Act, all provisions H.R. 6904, Patients Before Profits Act of 2022, all provisions H.R. 7116, 9-8-8 Implementation Act of 2022, all provisions H.R. 8890, Physician Wellness Program Act of 2022, all provisions H.R. 8908, Fighting Stimulant and other Substance Use Disorders Act, all provisions H.R. 8891, No Surprises for Survivors Act of 2022, all provisions H.R. 8885, Better Health Care Directories Act, all provisions H.R. 8886, Promoting Clarity in Mental Health and Substance Use Disorder Treatment Act, all provisions H.R. 8892, To direct the Secretary of Health and Human Services to conduct a public outreach campaign to inform individuals covered under a group health plan or group or individual health insurance coverage of Federal requirements relating to mental health and substance use disorder crisis services, and for other purposes, all provisions H.R. 8881, To amend the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1986 to require group health plans and health insurance issuers offering group or individual health insurance coverage to disclose the percentage of in-network participation for certain provider types, and for other purposes, all provisions H.R. 8889, Readable Insurance Coverage Explanations (RICE) Act, all provisions H.R. 7780, Mental Health Matters Act, all provisions H.R. 1667, Dr. Lorna Breen Health Care Provider Protection Act, all provisions H.R. 5224, Preventing Overdoses and Saving Lives Act of 2021, all provisions H.R. 6279, Opioid Treatment Access Act of 2022, all provisions H.R. 925, Data to Save Moms Act, all provisions H.R. 3352, Midwives for MOMS Act of 2021, all provisions H.R. 847, Promoting Digital Privacy Technologies Act, all provisions S. 224, Promoting Digital Privacy Technologies Act, all provisions H.R. 3771, South Asian Heart Health Awareness and Research Act of 2022, all provisions H.R. 7559, Prescription Information Modernization Act of 2022, all provisions H.R. 8289, Banning Misleading Drug Ads Act of 2022, all provisions Emergency Room Hero and Patient Safety Act No Surprises Act/implementation Global health security/pandemics Digital Health/AI/Digital Therapeutics Privacy/non-HIPAA covered health apps Abortion/Dobbs decision Drug overdose epidemic Telehealth Scope of practice/patient safety Prior authorization Physician burnout/mental health stigma Health equity/COVID-19 COVID-19 Provider Relief Fund COVID-91/testing/misinformation/vaccine issues/therapeutics Section 1557/nondiscrimination/limited English proficiency Maternal Mortality Modifier 25, Impossible Day Hunger, Nutrition and Health WIC/SNAP/Nutrition Strengthening primary health care Data privacy Physician-led aerospace medicine teams Men who have sex with men/blood donations Federally qualified health centers and clinical trials
Client expense: $4,360,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Federal Aviation Administration (FAA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
2022 · third_quarter · Health Issues
Issues concerning the dietary supplement industry, including 1) support for H.R.5214 (and eventual Senate Companion) - To amend the Internal Revenue Code of 1986 to permit expenditures from health savings accounts, flexible spending arrangements, and health reimbursement arrangements for dietary supplements. 2) Consideration of a Mandatory Product Listing for the Dietary Supplement Industry, to be housed at the FDA: S. 4090 3) For the natural substance known as N-Acetyl-L-Cysteine (NAC) to remain legal as a dietary supplement by the FDA. 4) S 4348 - FDA User Free Reauthorization Package (S. 4368) - did not support additional amendments added affecting the supplement industry
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Food Industry (safety, labeling, etc.)
Dietary Supplement Listing Act of 2022 (S. 4090); Mitigation of Emerging Zoonotic Diseases Act of 2021 (MEZDA)(no bill number); Updating DSHEA framework (DSHEA 2.0) (no bill number)
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
H.R. 4521 - America COMPETES Act: Provisions related to advanced pharmaceutical manufacturing and pharmaceutical supply chain resiliency. Fiscal Year 2023 Consolidated Appropriations Act; H.R. 7667 - Food and Drug Amendments of 2022: Provisions related to the Prescription Drug User Fee Reauthorization and FDA funding. S. 4090 - Dietary Supplement Listing Act of 2022: Provisions related to mandatory product listing for dietary supplements.
Client expense: $90,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Food Industry (safety, labeling, etc.)
FDA regulations and legislation affecting dietary supplements, medical foods and other natural products; regulations and legislation related to foods and dietary supplements containing CBD; Coronavirus impact and response; H.R.841, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021; FY2023 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (H.R.8239, S.4661); S.4090, Dietary Supplement Listing Act of 2022; H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; H.R.6833, Making continuing appropriations for fiscal year 2023, and for other purposes (P.L.117-180).
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Food Industry (safety, labeling, etc.)
Regulatory enforcement of dietary supplements, Mandatory product registration issues Food Safety regulation related issues S.4348, FDASLA Act of 2022, Mandatory product registration S.4090, Dietary Supplement Listing Act of 2022, Entirety H.R.7667, Food and Drug Amendments of 2022, Entirety Monitor the following: Over-the-counter dietary supplement products as qualified medical expenses under HSA/FSA's Regulatory enforcement of dietary supplements, Mandatory product registration issues H.R.5214, To amend the Internal Revenue Code of 1986 to permit expenditures from health savings accounts, flexible spending arrangements, and health reimbursement arrangements for dietary supplements, HSA/FSA supplement related issues Hemp-Derived Cannabidiol (CBD) regulations H.R.841, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021, generally S.1698, Hemp Access and Consumer Safety Act, Entirety S.2100, Personal Care Products Safety Act, Generally H.R.5747/S.1654, A bill to amend the Internal Revenue Code of 1986 to include certain over-the-counter dietary supplement products as qualified medical expenses, generally
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Food Industry (safety, labeling, etc.)
H.R.841 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 S.1698 - Hemp Access and Consumer Safety Act S. 4090 - Dietary Supplement Listing Act of 2022
Client expense: $142,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Food Industry (safety, labeling, etc.)
Potential dietary supplement mandatory product listing program (S. 4090), Dietary Supplement ListingAct, (S. 4348, Food and Drug Administration Safety and Landmark Advancement Act FDASLA, no House companion measure, FZy 2023 continuing resolution (PL 117-103).
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
HR 841 Issues related to regulation of dietary supplements S.1698 the Hemp Access and Consumer Safety Act S. 4090 Dietary Supplement Listing Act of 2022 S. 4348 the Food and Drug Administration Safety and Landmark Advancements Act of 2022 S.4591, the Cannabis Administration and Opportunity Act
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
For S.1654 - A bill to amend the Internal Revenue Code of 1986 to include certain over-the-counter dietary supplement products as qualified medical expenses; allowing HSA supplement deduction For S.4367 - A bill to amend the Internal Revenue Code of 1986 to eliminate limitations on contributions to health savings accounts; allowing HSA expansion ForS.3124 - National Patient ID Repeal Act; prohibiting the Patient Identification tracking Against H.R.550 - Immunization Infrastructure Modernization Act of 2021, nationalizing vaccine databases for easier tracking For Amending the Infrastructure Law (PL No: 117-58), to allow wired broadband, not just wireless For H.R.5816 - National Informed Consent Exemption (NICE) Act, allowing exemption for all federally-connected vaccines, and requiring government study of the unvaccinated (to restore Control Group science) Against S. 4090, Dietary Supplement Listing Act, to protect supplement manufacturers from bankruptcy
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Food Industry (safety, labeling, etc.)
S. 4090, Dietary Supplement Listing Act of 2022, a bill to improve transparency and the availability of information regarding dietary supplements by amending the Federal Food, Drug, and Cosmetic Act to require manufacturers of dietary supplements to list dietary supplements with the Food and Drug Administration.
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
HR 841 Issues related to regulation of dietary supplements S.1698 the Hemp Access and Consumer Safety Act S. 4090 Dietary Supplement Listing Act of 2022 S. 4348 the Food and Drug Administration Safety and Landmark Advancements Act of 2022
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Food Industry (safety, labeling, etc.)
Potential dietary supplement mandatory product listing program (S. 4090), Dietary Supplement ListingAct, (S. 4348, Food and Drug Administration Safety and Landmark Advancement Act FDASLA, no House companion measure.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
Lobbied in support of S. 1654 and H.R. 5747, legislation to include certain over-the-counter vitamins and minerals as qualified medical expenses. Lobbied in opposition of S. 4090, the Dietary Supplement Listing Act of 2022.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Food Industry (safety, labeling, etc.)
FDA regulations and legislation affecting dietary supplements, medical foods and other natural products; regulations and legislation related to foods and dietary supplements containing CBD; Coronavirus impact and response; H.R.841, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021; FY2023 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (H.R.8239, Senate); H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022; S.4090, Dietary Supplement Listing Act of 2022.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
S. 253, Cannabidiol and Marihuana Research Expansion Act, all provisions H.R. 6087, Improving Access to Workers Compensation for Injured Federal Workers Act of 2022, all provisions H.R. 3085, Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act of 2021, all provisions H.R. 5030, Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act, all provisions H.R. 1384, Mainstreaming Addiction Treatment (MAT) Act of 2021, all provisions S. 445, Mainstreaming Addiction Treatment (MAT) Act of 2021, all provisions H.R. 2067, Medication Access and Training Expansion (MATE) Act of 2021, all provisions S. 2235, Medication Access and Training Expansion (MATE) Act of 2021, all provisions H.R. 6072, Leveraging Integrated Networks in Communities (LINC) To Address Social Needs Act of 2021, provisions relating to social determinants of health, impact on mental health and social services S. 509, Leveraging Integrated Networks in Communities (LINC) To Address Social Needs Act of 2021, provisions relating to social determinants of health, impact on mental health and social services H.R. 379, Improving Social Determinants of Health Act of 2021, all provisions S. 104, Improving Social Determinants of Health Act of 2021, all provisions S. 3799, Prepare for and Respond to Existing Viruses, Emerging New Threats, and (PREVENT) Pandemics Act, all provisions H.R. 8, Bipartisan Background Checks Act of 2021, all provisions H.R. 1446, Enhanced Background Checks Act of 2021, all provisions S. 1675, Maternal Health Quality Improvement Act, all provisions H.R. 2163, Safe Step Act, all provisions S. 464, Safe Step Act, all provisions H.R. 666, Anti-Racism in Public Health Act of 2021, all provisions S. 162, Anti-Racism in Public Health Act of 2021, all provisions H.R. 5248, Temporary Responders for Immediate Aid in Grave Emergencies (TRIAGE) Act of 2021, all provisions H.R. 6311, Comprehensive Addiction Resources Emergency Act of 2021, all provisions S. 3418, Comprehensive Addiction Resources Emergency Act of 2021, all provisions H.R. 1364, Parity Enforcement Act of 2021, all provisions H.R. 3735, Parity Implementation Assistance Act, all provisions H.R. 7232, 9-8-8 and Parity Assistance Act of 2022, all provisions H.R. 7116, 9-8-8 Implementation Act of 2022, all provisions S. 2938, Bipartisan Safer Communities Act, all provisions S. 4090, Dietary Supplement Listing Act of 2022, all provisions S. 1675, Maternal Health Quality Improvement Act, all provisions H.R. 1667, Dr. Lorna Breen Health Care Provider Protection Act, all provisions S. 610, Dr. Lorna Breen Health Care Provider Protection Act, all provisions H.R. 3753, Parity Implementation Assistance Act, all provisions S. 1962, Parity Implementation Assistance Act, all provisions S. 3904, Healthcare Cybersecurity Act of 2022, all provisions H.R. 4128, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, all provisions S. 2209, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, all provisions H.R. 6000, Cures 2.0 Act, all provisions S. 2416, New Opportunities for Value that Extend Lives (NOVEL) Act of 2021, all provisions H.R. 8152, To provide consumers with foundational data privacy rights, create strong oversight mechanisms, and establish meaningful enforcement, all provisions H.R. 2377, Federal Extreme Risk Protection Order Act of 2022, all provisions H.R. 7910, Protecting Our Kids Act, all provisions S. 2938, Bipartisan Safer Communities Act, all provisions H.R. 7667, Food and Drug Amendments of 2022, all provisions H.R. 7666, Restoring Hope for Mental Health and Well-Being Act of 2022, all provisions H.R. 2503, Social Determinants Accelerator Act of 2021, all provisions S. 3039, Social Determinants Accelerator Act of 2021, all provisions H.R. 7192, Diagnostic Device Advisory Committee Act, all provisions H.R. 3085, Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act of 2021, all provisions H.R. 5218, Collaborate in an Orderly and Cohesive Manner Act, all provisions H.R. 7845, NIH Clinical Trial Diversity Act of 2022, all provisions H.R. 708, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act, all provisions S. 168, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act, all provisions H.R. 4480, Telehealth Coverage and Payment Parity Act, all provisions H.R. 7573, Telehealth Extension and Evaluation Act, all provisions S. 3593, Telehealth Extension and Evaluation Act, all provisions H.R. 5541, Primary and Virtual Care Affordability Act, all provisions H.R. 1306, National Coronavirus Commission Act of 2021, all provisions S. 412, National Coronavirus Commission Act of 2021, all provisions H.R. 1843, COVID-19 Hate Crimes Act, all provisions S. 937, COVID-19 Hate Crimes Act, all provisions H.R. 3778, Nullifying Opportunities for Variants to Infect and Decimate (NOVID) Act, all provisions S. 1976, Nullifying Opportunities for Variants to Infect and Decimate (NOVID) Act, all provisions H.R. 6904, Patients Before Profits Act of 2022, all provisions H.R. 7053, Hospital Inpatient Services Modernization Act, all provisions S. 3792, Hospital Inpatient Services Modernization Act, all provisions H.R. 1364, Parity Enforcement Act of 2021, all provisions H.R. 5224, Preventing Overdoses and Saving Lives Act of 2021, all provisions H.R. 6279, Opioid Treatment Access Act of 2022, all provisions H.R. 7234, Summer Barrow Prevention, Treatment, and Recovery Act, all provisions H.R. 3352, Midwives for MOMS Act of 2021, all provisions H.R. 847, Promoting Digital Privacy Technologies Act, all provisions S. 224, Promoting Digital Privacy Technologies Act, all provisions H.R. 3771, South Asian Heart Health Awareness and Research Act of 2021, all provisions H.R. 7559, Prescription Information Modernization Act of 2022, all provisions H.R. 8289, Banning Misleading Drug Ads Act of 2022, all provisions H.R. 3614, Menstrual Equity For All Act of 2021, all provisions No Surprises Act/implementation Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act, all provisions 21st Century Cures Act/implementation Maternal mortality Maternal health and inequities/FY 2023 funding Prior Authorization AMA Recovery Plan for Americas Physicians/telehealth/prior authorization/physician burnout/scope Section 2527(b) of the U.S. Innovation and Competition Act (USICA)/Open Access Language Retired Physician Re-entry COVID-19 telehealth flexibilities COVID-19/Vaccine distribution/Vaccines in physician offices Physician burnout and suicide COVID-19/Health Equity/vaccines COVID-19 response/testing/misinformation/therapeutics/Paxlovid Public Health Emergency COVID-19 Health Equity/Men who have sex with men/3-month blood donation use deferral Health Equity/Federally qualified health centers and clinical trials Womens Reproductive Health Medication Abortion Access Diabetes Provider Relief Fund/COVID-19 Electronic Health Records (EHR) Certification Data Privacy Hunger, Nutrition, and Health Digital Health/AI/Digital Therapeutics Monkeypox/testing/vaccination
Client expense: $4,550,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), President of the U.S., SENATE, Vice President of the U.S., White House Office
2022 · second_quarter · Health Issues
H.R. 4521 - America COMPETES Act: Provisions related to advanced pharmaceutical manufacturing and pharmaceutical supply chain resiliency. H.R. 2471 - FY22 Consolidated Appropriations Act, H.R. 7667 - Food and Drug Amendments of 2022, Prescription Drug User Fee Reauthorization: Provisions related to FDA funding. S. 4090 - Dietary Supplement Listing Act of 2022: Provisions related to mandatory product listing for dietary supplements.
Client expense: $90,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Food Industry (safety, labeling, etc.)
Toxic Free Food Act of 2021 (H.R.3699); FDASLA Act of 2022 (S. 4348); Dietary Supplement Listing Act of 2022 (S. 4090); Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S. 4348); Food and Drug Amendments of 2022 (H.R. 7667); Mitigation of Emerging Zoonotic Diseases Act of 2021 (MEZDA)(no bill number); Ensuring Safe and Toxic-Free Foods Act of 2022 (no bill number); Updating DSHEA framework (DSHEA 2.0) (no bill number)
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Food Industry (safety, labeling, etc.)
Regulatory enforcement of dietary supplements, Mandatory product registration issues Food Safety regulation related issues S.4348, FDASLA Act of 2022, Mandatory product registration S.4090, Dietary Supplement Listing Act of 2022, Entirety Monitor the following: Over-the-counter dietary supplement products as qualified medical expenses under HSA/FSA's Regulatory enforcement of dietary supplements, Mandatory product registration issues H.R.5214, To amend the Internal Revenue Code of 1986 to permit expenditures from health savings accounts, flexible spending arrangements, and health reimbursement arrangements for dietary supplements, HSA/FSA supplement related issues Hemp-Derived Cannabidiol (CBD) regulations H.R.841, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021, generally S.1698, Hemp Access and Consumer Safety Act, Entirety S.2100, Personal Care Products Safety Act, Generally H.R.5747/S.1654, A bill to amend the Internal Revenue Code of 1986 to include certain over-the-counter dietary supplement products as qualified medical expenses, generally H.R.7667, Food and Drug Amendments of 2022, Entirety
Client expense: Not reported · Firm income: $10,000
Government targets: SENATE
2022 · second_quarter · Consumer Issues/Safety/Products
Regulation of dietary supplements and natural products. Specifically related to mandatory product listing and increased authority for FDA to combat illegal supplements. S. 1698 and H.R. 841 to provide for regulation of CBD products. S.4090, Dietary Supplement Listing Act. S. 4348, FDASLA Act of 2022. SHOP SAFE Act H.R. 3429/S.1843. INFORM Consumers Act S. 936. America Competes Act of 2022, H.R. 4521.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Food Industry (safety, labeling, etc.)
Regulation of dietary supplements and natural products. Specifically related to mandatory product listing and increased authority for FDA to combat illegal supplements. S. 1698 and H.R. 841 to provide for regulation of CBD products. S.4090, Dietary Supplement Listing Act. S. 4348, FDASLA Act of 2022. SHOP SAFE Act H.R. 3429/S.1843. INFORM Consumers Act S. 936. America Competes Act of 2022, H.R. 4521.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Food Industry (safety, labeling, etc.)
Regulation of dietary supplements and natural products. Specifically related to mandatory product listing and increased authority for FDA to combat illegal supplements. S. 1698 and H.R. 841 to provide for regulation of CBD products. S.4090, Dietary Supplement Listing Act. S. 4348, FDASLA Act of 2022.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
Issues concerning the dietary supplement industry, including 1) support for H.R.5214 (and eventual Senate Companion) - To amend the Internal Revenue Code of 1986 to permit expenditures from health savings accounts, flexible spending arrangements, and health reimbursement arrangements for dietary supplements. 2) Consideration of a Mandatory Product Listing for the Dietary Supplement Industry, to be housed at the FDA: S. 4090 3) For the natural substance known as N-Acetyl-L-Cysteine (NAC) to remain legal as a dietary supplement by the FDA. 4) S 4348 - FDA User Free Reauthorization Package (S. 4368) - did not support additional amendments added affecting the supplement industry
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Food Industry (safety, labeling, etc.)
H.R.841 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 S.1698 - Hemp Access and Consumer Safety Act S. 4090 - Dietary Supplement Listing Act of 2022
Client expense: $160,270 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
For S.1654 - A bill to amend the Internal Revenue Code of 1986 to include certain over-the-counter dietary supplement products as qualified medical expenses; allowing HSA supplement deduction For S.4367 - A bill to amend the Internal Revenue Code of 1986 to eliminate limitations on contributions to health savings accounts; allowing HSA expansion ForS.3124 - National Patient ID Repeal Act; prohibiting the Patient Identification tracking Against H.R.550 - Immunization Infrastructure Modernization Act of 2021, nationalizing vaccine databases for easier tracking For Amending the Infrastructure Law (PL No: 117-58), to allow wired broadband, not just wireless For H.R.5816 - National Informed Consent Exemption (NICE) Act, allowing exemption for all federally-connected vaccines, and requiring government study of the unvaccinated (to restore Control Group science) Against S. 4090, Dietary Supplement Listing Act, to protect supplement manufacturers from bankruptcy
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE